In PV, mutations in the driver gene JAK2 can lead to sustained activation of JAK-STAT and its downstream pathways, which participate in regulating the proliferation and differentiation of hematopoietic cells [4]. The gene discussed is JAK2; the disease is acquired polycythemia vera.